PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Université de Paris, Paris, France. bruno.megarbane@lrb.aphp.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 2286610.26355/eurrev_202009_22866
?:doi
?:hasPublicationType
?:journal
  • European review for medical and pharmacological sciences
is ?:pmid of
?:pmid
?:pmid
  • 32965009
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.68
?:rankingScore_hIndex
  • 43
is ?:relation_isRelatedTo_publication of
?:title
  • Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all